GOLPH3L and ovarian cancer: Moreover, we show that GOLPH3L overexpression enhances cisplatin resistance, and that GOLPH3L silencing restores the sensitivity of ovarian cancer cells to cisplatin, through regulation of the NF-κB signaling pathway.